Table 3. Prevalence difference estimates.
Effect | Prevalence Difference* | 95% CI |
Difference in proportion of participants | ||
Gender of participant (male v female) | 0.04 | −0.02–0.47 |
Head of household prior knowledge of MDA | 0.22 | 0.09–0.35 |
Head of household prior knowledge of MDA (among households reporting MDA from a CDD) | 0.03 | −0.12–0.18 |
Head of household reported knowing MDA was for trachoma control | 0.36 | 0.12–0.47 |
Calculated with survey weights.